163 related articles for article (PubMed ID: 3218791)
21. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
Mayo DJ; Dimond EP; Kramer W; Horne MK
Oncol Nurs Forum; 1996 May; 23(4):671-5. PubMed ID: 8735325
[TBL] [Abstract][Full Text] [Related]
22. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
23. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
Lutze G; Presser HJ; Urbahn H
Z Gesamte Inn Med; 1989 Apr; 44(8):235-40. PubMed ID: 2662657
[TBL] [Abstract][Full Text] [Related]
24. Hyperfibrinogenemia and prolonged clotting times in a Turner syndrome patient with hepatocellular carcinoma.
Zhao X; Wang Z; Cao L; Zhang W; Bai X; Dong N; Yu Z; Ruan C
Blood Coagul Fibrinolysis; 2010 Jul; 21(5):398-405. PubMed ID: 20410814
[TBL] [Abstract][Full Text] [Related]
25. Effect of sodium heparin and antithrombin III concentration on activated partial thromboplastin time in the dog.
Hellebrekers LJ; Slappendel RJ; van den Brom WE
Am J Vet Res; 1985 Jul; 46(7):1460-2. PubMed ID: 4026027
[TBL] [Abstract][Full Text] [Related]
26. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
[TBL] [Abstract][Full Text] [Related]
27. The effect of aprotinin on the response of the activated partial thromboplastin time (APTT) to heparin.
Francis JL; Howard C
Blood Coagul Fibrinolysis; 1993 Feb; 4(1):35-40. PubMed ID: 7681330
[TBL] [Abstract][Full Text] [Related]
28. Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.
van den Besselaar AM; Meeuwisse-Braun J; Jansen-Grüter R; Bertina RM
Thromb Haemost; 1987 Apr; 57(2):226-31. PubMed ID: 3603414
[TBL] [Abstract][Full Text] [Related]
29. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
[TBL] [Abstract][Full Text] [Related]
30. Gender and inter-species influence on coagulation tests of rats and mice.
Lemini C; Jaimez R; Franco Y
Thromb Res; 2007; 120(3):415-9. PubMed ID: 17156826
[TBL] [Abstract][Full Text] [Related]
31. The effect of prophylactic heparin treatment on enhanced thrombin generation in pregnancy.
Bremme K; Lind H; Blombäck M
Obstet Gynecol; 1993 Jan; 81(1):78-83. PubMed ID: 8416465
[TBL] [Abstract][Full Text] [Related]
32. [Monitoring of heparin therapy with activated recalcification time].
Lutze G; Schlote A; Urbahn H
Z Gesamte Inn Med; 1981 Feb; 36(4):102-6. PubMed ID: 7222858
[TBL] [Abstract][Full Text] [Related]
33. Monitoring of heparin treatment. Comparison of thrombin time, activated partial thromboplastin time, and plasma heparin concentration, and analysis of the behavior of antithrombin III.
Bounameaux H; Marbet GA; Lämmle B; Eichlisberger R; Duckert F
Am J Clin Pathol; 1980 Jul; 74(1):68-73. PubMed ID: 7395817
[TBL] [Abstract][Full Text] [Related]
34. Heparin neutralising activity of whole blood in patients undergoing vascular surgery.
Harbourne T; Nicolaides AN; Golcman L; Shiffrin E
J Cardiovasc Surg (Torino); 1987; 28(1):22-5. PubMed ID: 3805107
[TBL] [Abstract][Full Text] [Related]
35. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time.
Dudek MM; Kent N; Gustafsson KM; Lindahl TL; Killard AJ
Anal Chem; 2011 Jan; 83(1):319-28. PubMed ID: 21121686
[TBL] [Abstract][Full Text] [Related]
36. Plasma thrombin clotting time and plasma fibrinogen in diabetes mellitus and atherosclerosis.
Banerjee RN; Kumar V; Sahni AL
Indian J Med Res; 1972 Oct; 60(10):1432-42. PubMed ID: 4661652
[No Abstract] [Full Text] [Related]
37. Determination of fibrinogen in plasma.
Morse EE; Viswanathan U
Ann Clin Lab Sci; 1978; 8(5):438-41. PubMed ID: 707979
[TBL] [Abstract][Full Text] [Related]
38. Thrombin time dilution test: a simple method for the control of heparin therapy.
Pizzuto J; García-Méndez S; de-la-Paz Reyna M; Morales MR; Avilés A; Zavala B; Gaos C
Thromb Haemost; 1979 Dec; 42(4):1276-85. PubMed ID: 542933
[No Abstract] [Full Text] [Related]
39. Development of a photometric assay for activated partial thromboplastin time and its application to the Cobas Bio centrifugal analyzer.
Becker U; Bartl K; Lill H; Wahlefeld AW
Thromb Res; 1985 Dec; 40(6):721-30. PubMed ID: 4089837
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the quantitative action of protamine and heparin on blood coagulation. Significance in clinical and laboratory usage.
Perkash A
Am J Clin Pathol; 1980 May; 73(5):676-81. PubMed ID: 7377134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
